Bromhexine Grindex

Selected form

Syrup

Method of action:

Treatment option:

Top 20 medicines with the same components:

Dosage (Posology) and method of administration

Syrup

Tablets for children

Inside (regardless of food intake), adults and children over 14 years — 8-16 mg (2-4 hours).spoons) 3 times a day, for children from 6 to 14 years — 4-8 mg (1-2 hours).spoons) 3 times a day, children from 2 to 6 years — 2-4 mg (1/2–1 hour).spoon) 3 times a day, for children under 2 years - 2 mg (1/2 teaspoon) 3 times a day. The course of treatment is from 4 to 28 days. In the course of treatment, it is recommended to consume a sufficient amount of liquid.

Inside, 1-2 tablets 3-4 times a day, children from 3 to 5 years-0.002 g, from 6 to 14 years-0.004 g 3 times a day. The course lasts from 4 to 28 days.

Undesirable effects

Syrup

Tablets for children

Rarely, with prolonged use — nausea, vomiting, dyspeptic phenomena, exacerbation of gastric ulcer and duodenal ulcer, increased levels of transaminases in the blood serum, allergic reactions (skin rash, rhinitis, etc.).

Dyspepsia, increased activity of aminotransferases.

Name of the medicinal product

Bromhexine Grindex

Qualitative and quantitative composition

Bromhexine

Pharmaceutical form

Syrup, Tablets for children

Therapeutic indications

Syrup

Tablets for children

Acute and chronic inflammatory diseases of the lungs, accompanied by the formation of difficult-to-separate viscous sputum (bronchial asthma, cystic fibrosis, tuberculosis, pneumonia, tracheobronchitis, obstructive bronchitis, bronchiectasis, emphysema of the lungs, pneumoconiosis), chest injuries.

Chronic inflammatory lung diseases (bronchial asthma, cystic fibrosis, tuberculosis, tracheobronchitis, spastic bronchitis, bronchiectasia, emphysema, pneumoconiosis), chest injuries, pre - and postoperative period.

Contraindications

Syrup

Tablets for children

Hypersensitivity, first trimester of pregnancy, breast-feeding.

Pregnancy (first trimester), childhood (up to 3 years).

Pharmacokinetic properties

After oral administration, almost completely (99%) is absorbed within 30 minutes. Bioavailability-80%, binds to plasma proteins, passes through the BBB and placental barrier. It is metabolized in the liver, partially with the formation of active metabolites. T_1/2 — 1 h, in the terminal phase-15 h (due to reverse diffusion from the tissues). It is excreted by the kidneys, with repeated use it can accumulate. Against the background of severe hepatic impairment, the clearance decreases, and in chronic renal failure, the excretion of metabolites is disrupted.

Pharmacotherapeutic group

Secretolytics and stimulants of motor function of the respiratory tract

Incompatibilities

Preparations containing codeine make it difficult to discharge liquefied sputum. Promotes the penetration of antibiotics, including tetracyclines, erythromycin, cephalexin and sulfonamides into the bronchial mucosa and lung tissue.